Cargando...
p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice
Alzheimer’s disease (AD) is a proteinopathy characterized by the accumulation of β-amyloid (Aβ) and tau. To date, clinical trials indicate that Aβ immunotherapy does not improve cognition. Consequently, it is critical to modulate other aspects of AD pathology. As such, tau represents an excellent ta...
Guardado en:
| Publicado en: | Neurosci Lett |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4437620/ https://ncbi.nlm.nih.gov/pubmed/24887583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2014.05.047 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|